Zurcher Kantonalbank (Zurich Cantonalbank) Capricor Therapeutics, Inc. Transaction History
Zurcher Kantonalbank (Zurich Cantonalbank)
- $34.1 Billion
- Q4 2024
A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Capricor Therapeutics, Inc. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 10,084 shares of CAPR stock, worth $135,226. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,084Holding current value
$135,226% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CAPR
# of Institutions
108Shares Held
9.41MCall Options Held
1.79MPut Options Held
1.4M-
Vanguard Group Inc Valley Forge, PA2.28MShares$30.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.63MShares$21.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA879KShares$11.8 Million0.0% of portfolio
-
State Street Corp Boston, MA512KShares$6.87 Million0.0% of portfolio
-
Superstring Capital Management LP New York, NY337KShares$4.52 Million4.49% of portfolio
About CAPRICOR THERAPEUTICS, INC.
- Ticker CAPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,346,200
- Market Cap $326M
- Description
- Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...